October is the month dedicated to the prevention of women's cancers, with a special focus on breast cancer, which is still the most diagnosed malignancy among women. It is the time of year when the message of prevention, early detection and informed information resonates the loudest.
But there is one aspect of prevention that is still little known: genetic predisposition to female cancers.
Some forms of breast and ovarian cancer are caused not only by environmental or lifestyle factors, but by inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes. Having such a mutation does not mean getting sick, but it does imply an increased risk, which can be monitored and managed with personalized prevention pathways.
Detecting a genetic predisposition early can guide better clinical decisions, enable intensive surveillance programs, and protect not only one's own health but also that of family members.
At Life Clinic, specific genetic testing for hereditary risk assessment related to women's cancers can be performed throughan informed pathway alongside our professionals.
This pathway includes one-on-one specialized counseling, a blood draw, and postexamination medical support to interpret results and determine possible prevention or surveillance strategies.
The service is intended for all women, particularly those who have a family history of breast, ovarian or uterine cancer, or who wish to learn more about their genetic risk. Today more than ever, prevention means not only getting regular checkups, but also knowing one's family history, gathering information, and making informed choices. Knowing one's genetic profile is an act of responsibility and love toward oneself and future generations.
